Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB: Safety Overview

Metric LEDIPASVIR\SOFOSBUVIR LENIOLISIB
Total FAERS Reports 23,616 570
Deaths Reported 1,371 6
Death Rate 5.8% 1.1%
Hospitalizations 4,031 54
Average Patient Age 57.9 yrs 19.4 yrs
% Female Patients 42.9% 27.3%
FDA Approval Date N/A Mar 24, 2023
Manufacturer N/A Pharming Healthcare Inc.
Route N/A ORAL
Marketing Status N/A Prescription